Mo1887 ASSESSING DISEASE SEVERITY IN PEDIATRIC IBD PATIENTS USING FECAL CALPROTECTIN AND MACHINE LEARNING
Tu1957 HIGH FIBER SUPPLEMENTATION ALTERS HUMAN FECAL MICROBIOME: PRELIMINARY FINDINGS OF THE ALASKA FIBER INTERVENTION RESEARCH STUDY (FIRST)
40 EFFECTS OF LYOPHILIZED FECAL FILTRATE COMPARED TO LYOPHILIZED DONOR STOOL IN THE TREATMENT OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION: A ...
581 ANALYSIS OF FECAL AND MUCOSA-ASSOCIATED MICROBIOTA IN PATIENTS WITH COLORECTAL ADENOMA AND EARLY COLORECTAL CANCER
Mo1032 DELAYS IN DIAGNOSTIC COLONOSCOPY AFTER POSITIVE FECAL IMMUNOHISTOCHEMICAL TESTING DURING THE COVID-19 PANDEMIC
Fecal microbiota transplantation for recurrent C. difficile infection can be the best therapeutic option in severely immunocompromised patients depending on ...
In more than half of the colorectal cancer (CRC) screening participants with a positive fecal immunochemical test (FIT) result, no advanced neoplasia (AN) ...
Very few medical conditions are reported 100 percent of the time. Some patients avoid seeking medical treatment, while others fail to bring symptoms to the ...
Unlocking the potential of fecal virome transplants (FVT): modulating the gut-brain axis in stress-related disorders
Fecal microbiota transplantation (FMT) is the cornerstone for the management of recurrent Clostridioides difficile infection (rCDI) with high clinical ...